Literature DB >> 20389046

Is pure laparoscopic radical cystectomy still an attractive solution for the treatment of muscle-invasive bladder cancer?

Piotr Chlosta1, Tomasz Drewa, Jakub Dobruch, Artur Antoniewicz, Pawel Olejniczak, Mateusz Obarzanowski, Andrzej Borowka.   

Abstract

OBJECTIVE: The aim of this study is to report our experience with laparoscopic radical cystectomy (LRC), evaluating the technique and perioperative and pathological outcomes.
METHODS: 47 LRCs were performed due to muscle-invasive bladder cancer. Conduits were performed in 23 patients and neobladders in 23 (one bi-intestinal). One ureterocutaneostomy was created.
RESULTS: In 43 patients LRC was performed with minilaparotomy for urinary diversion. The mean operation time was 290 min. Four operations were converted. Complications included sigmoid colon injury, urinary leak, lymphatic leak, short-term paralytic ileus, and heart attack. Mean blood loss was 220 ml. Hospitalization time was 6 days. Tumor stage was pT2b, pT3a, pT3b, and pT4a in 28, 13, 5, and 1 patient, respectively. No positive margins were found. The mean number of lymph nodules was 17, while in the last 25 procedures it was 21. 17% of patients had tumor in the lymph nodes. The mean follow-up was 10 months. Local recurrence and dissemination was observed in 2%. Continence in patients receiving neobladder was fully satisfactory.
CONCLUSIONS: More complications are related to neobladder than to ileac conduit. LRC with minilaparotomy seems to be an attractive treatment option for patients with muscle-invasive bladder cancer. Radical cystectomy performed intracorporeally could be reserved for 'robot-assisted' operations.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20389046     DOI: 10.1159/000310349

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  7 in total

1.  [Radical cystectomy - pro laparoscopic].

Authors:  J Rassweiler; K Godin; A S Goezen; D Kusche; P Chlosta; F Gaboardi; C C Abbou; R van Velthoven
Journal:  Urologe A       Date:  2012-05       Impact factor: 0.639

Review 2.  Current trends in minimally invasive reconstructive urology.

Authors:  I Belibasakis; G Kolostoumpis; K Makrygiannaki
Journal:  J Robot Surg       Date:  2011-11-05

Review 3.  Tissue engineering for the oncologic urinary bladder.

Authors:  Tomasz Drewa; Jan Adamowicz; Arun Sharma
Journal:  Nat Rev Urol       Date:  2012-08-21       Impact factor: 14.432

4.  Single-session laparoscopic cystectomy and nephroureterectomy.

Authors:  Marcin Słojewski; Piotr Chłosta; Marek Myślak; Grzegorz Herlinger; Piotr Dobroński; Piotr Kryst; Tomasz Drewa
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2012-11-26       Impact factor: 1.195

5.  Bladder cancer--the neglected tumor: a descriptive analysis of publications referenced in MEDLINE and data from the register ClinicalTrials.gov.

Authors:  Frank Kunath; Steffen F Krause; Bernd Wullich; Peter J Goebell; Dirk G Engehausen; Maximilian Burger; Joerg J Meerpohl; Bastian Keck
Journal:  BMC Urol       Date:  2013-10-24       Impact factor: 2.264

6.  Lymph node dissection during laparoscopic (LRC) and open (ORC) radical cystectomy due to muscle invasive bladder urothelial cancer (pT2-3, TCC).

Authors:  Piotr Chlosta; Tomasz Drewa; Jerzy Siekiera; Jarosław Jaskulski; Andrzej Petrus; Krzysztof Kamecki; Witold Mikołajczak; Mateusz Obarzanowski; Andrzej Wronczewski; Krzysztof Krasnicki; Milosz Jasinski
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2011-09-30       Impact factor: 1.195

Review 7.  Tissue engineering of urinary bladder - current state of art and future perspectives.

Authors:  Jan Adamowicz; Tomasz Kowalczyk; Tomasz Drewa
Journal:  Cent European J Urol       Date:  2013-08-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.